Skip to main content
. 2024 Aug 27;40(5):1126–1130. doi: 10.1002/joa3.13139

TABLE 2.

Reasons for oral coagulant ineligibility in the patients taking edoxaban 15 mg OD.

Severe kidney impairment (creatinine clearance <30 mL/min), n (%) 4 (21.1)
History of bleeding from critical area or organ, n (%) 4 (21.1)
Intracranial 0
Gastrointestinal 0
Intraocular 0
Others a 4 (21.1)
Low body weight (≦45 kg), n (%) 5 (26.3)
Continuous use of NSAIDs, n (%) 0
Use of an antiplatelet drug, n (%) 5 (26.3)
Aspirin 0
Clopidogrel 4 (21.1)
Other 1 (5.3)
a

The details are as follows (bloody sputum: 2, iron deficiency anemia: 2). The exact source of bleeding is unknown in either patient.